 SAN DIEGO, Oct. 19, 2021 GLOBE NEWSWIRE -- Progenity, Inc. Nasdaq: PROG, an innovative biotechnology company, announced today that the company will participate in the fourth annual IBD Innovate Product Development for Crohns Colitis virtual conference, hosted by the Crohns Colitis Foundation, November 18-19, 2021. 